ArticlePharmaceutics2025

Compound KTI-2338 Inhibits ACVR1 Receptor Signaling in Fibrodysplasia Ossificans Progressiva.

Neeltje M Rosenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.